Sunshine Biopharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Sunshine Biopharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Canada
- Ticker symbol
- SBFM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001402328
Board of directors
- Since 2026
-
Steve N. Slilaty · Director · Chief Executive OfficerSince 2024
Chief executives
Steve N. Slilaty
· Chief Executive Officer
Dates unknown
Board connections
1 of this board's directors also sit on 6 other boards.
- via David Natan
- via David Natan
- via David Natan
- via David Natan
- via David Natan
- via David Natan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | David Natan Director | Grant or award | +58,300 | — | — |
| Apr 14, 2026 | David Natan Director | Grant or award | +100,000 | — | — |
| Mar 4, 2024 | Steve N. Slilaty Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +100,000 | $0.10 | $10,000 |
| Feb 8, 2024 | Steve N. Slilaty Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +20,000 | $0.10 | $2,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.